Literature DB >> 3345529

Reversal of transformed phenotypes by herbimycin A in src oncogene expressed rat fibroblasts.

Y Murakami1, S Mizuno, M Hori, Y Uehara.   

Abstract

We studied the effectiveness of herbimycin A, an inhibitor of the function of the src oncogene, to reverse the various transformed phenotypes in normal rat kidney (NRK) cells integrating temperature-sensitive v-src (ts/NRK). Elevated glucose transport in ts/NRK cells at a permissive temperature (33 degrees C) was decreased by herbimycin in 8 h to near the level that was observed either in ts/NRK grown at a nonpermissive temperature (39 degrees C) or in untransformed NRK cells at either temperature. Herbimycin caused no significant decrease in glucose uptake in ts/NRK cells grown at 39 degrees C. The effects of herbimycin on serum- and anchorage-independent growth properties of ts/NRK cells and of NRK cells integrating K-ras (KNRK) were also examined. With ts/NRK cells grown at 33 degrees C, the inhibition of cell growth by herbimycin became more pronounced when the serum concentration in the medium was lowered. With KNRK cells, in contrast, almost the same extent of cell growth inhibition was exerted by herbimycin irrespective of the serum concentration. Furthermore, with ts/NRK cells grown at 33 degrees C, herbimycin inhibited the colony formation in the soft agar medium more strongly than on a solid support. No such differential effects were observed with KNRK cells under similar conditions. These results suggest that herbimycin specifically acts on cells expressing the src oncogene and reverses various transformed characteristics to the normal ones.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3345529

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  10 in total

1.  The oncoprotein kinase chaperone CDC37 functions as an oncogene in mice and collaborates with both c-myc and cyclin D1 in transformation of multiple tissues.

Authors:  L Stepanova; M Finegold; F DeMayo; E V Schmidt; J W Harper
Journal:  Mol Cell Biol       Date:  2000-06       Impact factor: 4.272

2.  A unifying model of the cell proliferation emphasizing plasma membrane fluxes.

Authors:  E Cervén
Journal:  Experientia       Date:  1990-10-15

3.  A Cell-Cell Communication Marker for Identifying Targeted Tumor Therapies.

Authors:  Diane F Matesic; Amna Ali; Tatyana S Sidorova; Timothy J Burns
Journal:  Curr Bioact Compd       Date:  2013

4.  Amino-group carrier-protein-mediated secondary metabolite biosynthesis in Streptomyces.

Authors:  Fumihito Hasebe; Kenichi Matsuda; Taro Shiraishi; Yushi Futamura; Takeshi Nakano; Takeo Tomita; Ken Ishigami; Hikari Taka; Reiko Mineki; Tsutomu Fujimura; Hiroyuki Osada; Tomohisa Kuzuyama; Makoto Nishiyama
Journal:  Nat Chem Biol       Date:  2016-09-26       Impact factor: 15.040

Review 5.  Signal transduction pathways and their relevance in human astrocytomas.

Authors:  M M Feldkamp; N Lau; A Guha
Journal:  J Neurooncol       Date:  1997-12       Impact factor: 4.130

6.  Mitochondrial proliferation and paradoxical membrane depolarization during terminal differentiation and apoptosis in a human colon carcinoma cell line.

Authors:  M Mancini; B O Anderson; E Caldwell; M Sedghinasab; P B Paty; D M Hockenbery
Journal:  J Cell Biol       Date:  1997-07-28       Impact factor: 10.539

7.  Organ site-dependent expression of basic fibroblast growth factor in human renal cell carcinoma cells.

Authors:  R K Singh; C D Bucana; M Gutman; D Fan; M R Wilson; I J Fidler
Journal:  Am J Pathol       Date:  1994-08       Impact factor: 4.307

8.  Cadherin-mediated cell-cell adhesion is perturbed by v-src tyrosine phosphorylation in metastatic fibroblasts.

Authors:  N Matsuyoshi; M Hamaguchi; S Taniguchi; A Nagafuchi; S Tsukita; M Takeichi
Journal:  J Cell Biol       Date:  1992-08       Impact factor: 10.539

9.  Reversible suppression by nalidixic acid of anchorage-independent growth of mouse cells transformed by 3-methylcholanthrene or an activated c-Ha-ras gene.

Authors:  M Kaneko; J Horikoshi
Journal:  Br J Cancer       Date:  1989-12       Impact factor: 7.640

10.  Induction of in vitro differentiation of mouse embryonal carcinoma (F9) and erythroleukemia (MEL) cells by herbimycin A, an inhibitor of protein phosphorylation.

Authors:  K Kondo; T Watanabe; H Sasaki; Y Uehara; M Oishi
Journal:  J Cell Biol       Date:  1989-07       Impact factor: 10.539

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.